1. Construction of meloxicam and bupivacaine co-delivery nanosystem based on the pathophysiological environment of surgical injuries for enhanced postoperative analgesia.
- Author
-
Li, Mohan, He, Yumiao, Liu, Zongran, Ma, Xu, Sun, Fengrun, Pei, Lijian, Ma, Chao, Liu, Hongju, Ji, Tianjiao, and Huang, Yuguang
- Subjects
POSTOPERATIVE pain treatment ,SURGICAL complications ,PAIN management ,PERIPHERAL nerve injuries ,ANALGESIA ,LOCAL anesthetics ,BUPIVACAINE - Abstract
Besides peripheral nerve injury, the acute inflammation is one of the pathological features of tissues after surgery, which exacerbates the postoperative pain, especially in the first 48 h after the surgery. Multimodal analgesia (MMA), such as the combination of non-steroidal anti-inflammatory drugs (NSAIDs) with local anesthetics, has shown enhanced potency compared with the usage of local anesthetics alone. However, rare formulations can provide long-term analgesia at a single dose. Herein, bupivacaine (BUP, a local anesthetic) loading poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPB) were coated with meloxicam (MLX, an NSAID) loading lipid bilayer (LPM), forming a core–shell nanosystem (NPB@LPM) to provide enhanced and long-term analgesia to treat postoperative pain. MLX was encapsulated in the lipid shell, which enabled high dose MLX to be released in the first 48 h after surgery to reduce the acute inflammation induced pain. BUP was encapsulated in the PLGA core to provide a long-term release for the nerve block. This nanosystem provided a 7-day (whole recovery cycle) effective analgesia in the Brennan's plantar incision rat model. The tissue reactions of NPB@LPM are benign. This work will provide feasible strategies on designing drug delivery systems for postoperative pain management. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF